Improving tumor budding reporting in colorectal cancer: a Delphi consensus study

Tumor budding is a long-established independent adverse prognostic marker in colorectal cancer, yet methods for its assessment have varied widely. In an effort to standardize its reporting, a group of experts met in Bern, Switzerland, in 2016 to reach consensus on a single, international, evidence-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Haddad, Tariq Sami, Lugli, Alessandro, Aherne, Susan, Barresi, Valeria, Terris, Benoît, Bokhorst, John-Melle, Brockmoeller, Scarlet Fiona, Cuatrecasas, Miriam, Simmer, Femke, El-Zimaity, Hala, Fléjou, Jean-François, Gibbons, David, Cathomas, Gieri, Kirsch, Richard, Kuhlmann, Tine Plato, Langner, Cord, Loughrey, Maurice B., Riddell, Robert, Ristimäki, Ari, Kakar, Sanjay, Sheahan, Kieran, Treanor, Darren, van der Laak, Jeroen, Vieth, Michael, Zlobec, Inti, Nagtegaal, Iris D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448718/
https://www.ncbi.nlm.nih.gov/pubmed/33650042
http://dx.doi.org/10.1007/s00428-021-03059-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448718/
https://www.ncbi.nlm.nih.gov/pubmed/33650042
http://dx.doi.org/10.1007/s00428-021-03059-9

Ejemplares similares